 hepat viru infect chronic liver diseas children leukemia long-term remiss antibodi hepat viru hcv sera leukem children chronic liver diseas cld year therapi withdraw patient anti-hcv regular interv ortho-enzyme-link immunosorb assay elisa test case reactiv sera recombin assay specif result elisa twelv case posit group anti-hcv+ posit group neg mean sgpt peak follow-up group sgpt off-therapi case group group group histolog avail patient sign chronic hepat patient group patient group sever liver lesion result hcv signific role etiolog chronic hepat leukem patient persist anti-hcv activ sever cld final prognosi children leukemia